-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
AbCellera Biologics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
- AbCellera Biologics Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$93.5M, a 81.9% decline year-over-year.
- AbCellera Biologics Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$269M, a 132% decline year-over-year.
- AbCellera Biologics Inc. annual Operating Income (Loss) for 2023 was -$237M, a 210% decline from 2022.
- AbCellera Biologics Inc. annual Operating Income (Loss) for 2022 was $217M, a 5.92% increase from 2021.
- AbCellera Biologics Inc. annual Operating Income (Loss) for 2021 was $204M, a 31% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)